A cross-sectional study evaluated oncology nurses' readiness, knowledge, and confidence in incorporating genomics into practice to identify educational needs for cancer care.

What Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 6.1% in the morning session after Bank of America raised its price target on the stock to $80 from $50 while keeping a Neutral ...

Much of what scientists know about how genetic differences affect health comes from studying populations outside Africa. This matters because genetic information is increasingly being used to ...

WhiteLab Genomics has raised $26 million in Series B financing to expand its artificial intelligence platform for designing ...

PRNewswire/ -- (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, ...

Cancer genomics is the study of the totality of DNA sequence and gene expression differences between tumour cells and normal host cells. It aims to understand the genetic basis of tumour cell ...

The era of predictive genomics is rapidly reshaping how we think about disease, risk and lifelong health. Recent advances in whole-genome sequencing have equipped clinicians with insights into our ...

Helio Genomics today announced four poster presentations at the San Antonio Liver Cancer Symposium (SALCS), October 8–9, evaluating HelioLiver™ Dx in hepatocellular carcinoma (HCC) surveillance.

For decades, cancer treatment has largely followed a one-size-fits-all approach: the same chemotherapy regimen given to every ...

A member of Joanna Kelley's lab talks with symposium participants about a project to sequence the genomes of North American brown bears. Photos by Carolyn Lagattuta. California is losing its living ...

Veracyte will pay $150 million upfront in cash, plus up to $30 million based on milestones related to UroAmp reimbursement. The company had already included Convergent's operating costs in its 2026 ...